These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 17638401

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
    Melnikova VO, Bezdetnaya LN, Potapenko AY, Guillemin F.
    Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
    [Abstract] [Full Text] [Related]

  • 3. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin.
    Triesscheijn M, Ruevekamp M, Aalders M, Baas P, Stewart FA.
    Photochem Photobiol; 2004 Oct; 80(2):236-41. PubMed ID: 15362947
    [Abstract] [Full Text] [Related]

  • 4. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response.
    Triesscheijn M, Ruevekamp M, Aalders M, Baas P, Stewart FA.
    Photochem Photobiol; 2005 Oct; 81(5):1161-7. PubMed ID: 15934792
    [Abstract] [Full Text] [Related]

  • 5. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
    Rovers JP, Saarnak AE, Molina A, Schuitmaker JJ, Sterenborg HJ, Terpstra OT.
    Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
    [Abstract] [Full Text] [Related]

  • 6. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells.
    Dysart JS, Singh G, Patterson MS.
    Photochem Photobiol; 2005 Oct; 81(1):196-205. PubMed ID: 15469385
    [Abstract] [Full Text] [Related]

  • 7. Characterization of photodegradation of meta-tetra(hydroxyphenyl)chlorin (mTHPC) in solution: biological consequences in human tumor cells.
    Belitchenko I, Melnikova V, Bezdetnaya L, Rezzoug H, Merlin JL, Potapenko A, Guillemin F.
    Photochem Photobiol; 1998 May; 67(5):584-90. PubMed ID: 9613242
    [Abstract] [Full Text] [Related]

  • 8. The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins.
    Compagnin C, Baù L, Mognato M, Celotti L, Miotto G, Arduini M, Moret F, Fede C, Selvestrel F, Rio Echevarria IM, Mancin F, Reddi E.
    Nanotechnology; 2009 Aug 26; 20(34):345101. PubMed ID: 19652275
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy.
    Glanzmann T, Hadjur C, Zellweger M, Grosiean P, Forrer M, Ballini JP, Monnier P, van den Bergh H, Lim CK, Wagnières G.
    Photochem Photobiol; 1998 May 26; 67(5):596-602. PubMed ID: 9613244
    [Abstract] [Full Text] [Related]

  • 10. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light.
    Pittet O, Petermann D, Michod D, Krueger T, Cheng C, Ris HB, Widmann C.
    J Photochem Photobiol B; 2007 Jul 27; 88(1):29-35. PubMed ID: 17560792
    [Abstract] [Full Text] [Related]

  • 11. Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.
    Mitra S, Foster TH.
    Photochem Photobiol; 2005 Jul 27; 81(4):849-59. PubMed ID: 15807635
    [Abstract] [Full Text] [Related]

  • 12. Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity.
    Coutier S, Bezdetnaya L, Marchal S, Melnikova V, Belitchenko I, Merlin JL, Guillemin F.
    Br J Cancer; 1999 Sep 27; 81(1):37-42. PubMed ID: 10487610
    [Abstract] [Full Text] [Related]

  • 13. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 27; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 14. Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells.
    Dysart JS, Patterson MS, Farrell TJ, Singh G.
    Photochem Photobiol; 2002 Mar 27; 75(3):289-95. PubMed ID: 11950095
    [Abstract] [Full Text] [Related]

  • 15. Effect of meta-tetra(hydroxyphenyl)chlorin (mTHPC)-mediated photodynamic therapy on sensitive and multidrug-resistant human breast cancer cells.
    Teiten MH, Bezdetnaya L, Merlin JL, Bour-Dill C, Pauly ME, Dicato M, Guillemin F.
    J Photochem Photobiol B; 2001 Sep 15; 62(3):146-52. PubMed ID: 11566278
    [Abstract] [Full Text] [Related]

  • 16. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
    Kiesslich T, Berlanda J, Plaetzer K, Krammer B, Berr F.
    Photochem Photobiol Sci; 2007 Jun 15; 6(6):619-27. PubMed ID: 17549263
    [Abstract] [Full Text] [Related]

  • 17. Tissue levels, histologic changes and plasma pharmacokinetics of meta-Tetra (hydroxyphenyl) chlorin (mTHPC) in the cat.
    Campbell GA, Bartels KE, Arnold C, Healey T, Cowell RL, Lucroy MD, Ronn AM.
    Lasers Med Sci; 2002 Jun 15; 17(2):79-85. PubMed ID: 12111590
    [Abstract] [Full Text] [Related]

  • 18. Correlation of photodynamic activity and fluorescence signaling for free and pegylated mTHPC in mesothelioma xenografts.
    Tran N, Krueger T, Pan Y, Yan H, Cheng C, Altermatt HJ, Ballini JP, Borle F, Ris HB, Andrejevic-Blant S.
    Lasers Surg Med; 2007 Mar 15; 39(3):237-44. PubMed ID: 17345623
    [Abstract] [Full Text] [Related]

  • 19. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
    Triesscheijn M, Ruevekamp M, Out R, Van Berkel TJ, Schellens J, Baas P, Stewart FA.
    Cancer Chemother Pharmacol; 2007 Jun 15; 60(1):113-22. PubMed ID: 17009028
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
    Glanzmann T, Forrer M, Blant SA, Woodtli A, Grosjean P, Braichotte D, van den Bergh H, Monnier P, Wagnières G.
    J Photochem Photobiol B; 2000 Aug 15; 57(1):22-32. PubMed ID: 11100834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.